We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Metformin and the risk of neurodegenerative diseases in patients with diabetes: A meta‐analysis of population‐based cohort studies.
- Authors
Zhang, Yunnan; Zhang, Yi; Shi, Xiujin; Han, Jialun; Lin, Baidi; Peng, Wenxing; Mei, Zubing; Lin, Yang
- Abstract
Aims: The association between metformin use and neurodegenerative disease (ND) onset remains controversial. In this systematic review and meta‐analysis, we aimed to determine the relationship between metformin use and ND risk based on data from population‐based cohort studies. Methods: Articles were systematically searched in PubMed, EMBASE and Cochrane Library databases. Pooled relative risks (RRs) with 95% CIs were obtained using a random‐effects model. Subgroup analyses, sensitivity analyses and meta‐regression were performed to identify the sources of heterogeneity and strengthen the results. Results: Twelve population‐based cohort studies involving 194,792 participants (94,462 metformin users and 100,330 metformin non‐users) were eligible for inclusion in this meta‐analysis. The pooled RR of NDs reached 0.77 (95% CI 0.67–0.88) when comparing metformin users with non‐users. The effects were more prominent in long‐term metformin users (≥4 years) (RR 0.29, 95% CI 0.13–0.44) and studies from Asian countries (RR 0.69, 95% CI 0.64–0.74). The effect estimates were stable when stratified by subtypes of NDs, study designs, and control definitions (p for interaction >0.05). Meta‐regression did not identify the coefficients as the sources of heterogeneity (all p > 0.05). Conclusions: This systematic review and meta‐analysis found that metformin use, especially long‐term use, was associated with lower ND risk. However, because there was substantial heterogeneity among studies, high‐quality randomized controlled trials are still needed to confirm this finding.
- Subjects
RISK factors of neurodegeneration; ONLINE information services; MEDICAL databases; RELATIVE medical risk; MEDICAL information storage &; retrieval systems; CONFIDENCE intervals; META-analysis; SYSTEMATIC reviews; REGRESSION analysis; TYPE 2 diabetes; DESCRIPTIVE statistics; METFORMIN; MEDLINE; ODDS ratio; SENSITIVITY &; specificity (Statistics)
- Publication
Diabetic Medicine, 2022, Vol 39, Issue 6, p1
- ISSN
0742-3071
- Publication type
Article
- DOI
10.1111/dme.14821